Home » Topics » BioWorld Science

BioWorld Science
RSS

Post-herpetic neuralgia data reviewed

July 5, 1996

MedImmune seeks Canadian approval for RespiGam

July 5, 1996

BMS describes antifungal effects of ascosteroside

July 5, 1996

Amphocil safe, effective in BMT patients

July 5, 1996

FDA issues nonapprovable letter for Avita; development elsewhere on track

July 5, 1996

ProCyte launches Iamin gel in U.S.

July 5, 1996

Lilly's 5-HT1F agonists for migraine

July 5, 1996

Vasodilator cream shows positive results in trials

June 28, 1996

Zonagen's Vasomax covered under U.S. patent

June 28, 1996

Merck & Co. reveals growth hormone release promoters

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...